BioCytics, Inc.
BioCytics is a biotechnology company focused on cancer immunotherapy, dedicated to researching and developing novel cellular therapies for diseases and accelerating personalized medicine to market. Located in Huntersville, North Carolina, it collaborates with industry leaders in biospecimen banking, cell manufacturing, and clinical trials, with a mission to provide comprehensive patient care and develop therapies for solid tumors. The company is engaged in diverse immune effector cell research, leveraging the intrinsic specificity of autologous immune cells to treat solid tumors, and is actively seeking collaborations for the development of novel and combination therapies in oncology.
Industries
Nr. of Employees
small (1-50)
BioCytics, Inc.
Huntersville, North Carolina, United States, North America
Products
Integrated clinical informatics platform
A digitally integrated platform for cellular therapy trials combining an openEHR-based EMR, EDC/CDM for agile eCRF design and real-time validation, laboratory/biobank documentation and inventory tracking, and CTMS for trial administration.
Integrated clinical informatics platform
A digitally integrated platform for cellular therapy trials combining an openEHR-based EMR, EDC/CDM for agile eCRF design and real-time validation, laboratory/biobank documentation and inventory tracking, and CTMS for trial administration.
Services
Process & Assay Development (CDMO)
Custom development and optimization of cell processing workflows and analytical assays to support preclinical development and IND-enabling activities.
cGMP Manufacturing for Early-Phase Cell Therapies
cGMP-compliant production of cell therapy products in ISO-classified cleanrooms using closed-system and automated platforms to support Phase I studies and point-of-care models.
Early-Phase CRO Services
End-to-end services for feasibility, initiation, execution and completion of early-phase immuno-oncology and cell therapy clinical trials, including regulatory and safety oversight.
Clinical Laboratory Diagnostics (CLIA-level)
On-site high-complexity clinical laboratory testing covering routine and specialized assays with external proficiency enrollment and accredited quality systems.
Translational Analytical Services
Research-use analytical testing including immune phenotyping, potency and cytotoxicity assays, instrument/reagent qualification, and custom assay development to support discovery and IND-enabling work.
BioBanking and Biospecimen Procurement
IRB-approved biospecimen collection, long-term controlled storage, and sourcing of annotated samples (leukapheresis, PBMCs, tumor tissue, CTCs, biofluids) for translational research.
Process & Assay Development (CDMO)
Custom development and optimization of cell processing workflows and analytical assays to support preclinical development and IND-enabling activities.
cGMP Manufacturing for Early-Phase Cell Therapies
cGMP-compliant production of cell therapy products in ISO-classified cleanrooms using closed-system and automated platforms to support Phase I studies and point-of-care models.
Early-Phase CRO Services
End-to-end services for feasibility, initiation, execution and completion of early-phase immuno-oncology and cell therapy clinical trials, including regulatory and safety oversight.
Clinical Laboratory Diagnostics (CLIA-level)
On-site high-complexity clinical laboratory testing covering routine and specialized assays with external proficiency enrollment and accredited quality systems.
Translational Analytical Services
Research-use analytical testing including immune phenotyping, potency and cytotoxicity assays, instrument/reagent qualification, and custom assay development to support discovery and IND-enabling work.
BioBanking and Biospecimen Procurement
IRB-approved biospecimen collection, long-term controlled storage, and sourcing of annotated samples (leukapheresis, PBMCs, tumor tissue, CTCs, biofluids) for translational research.
Expertise Areas
- Early-phase cell and gene therapy manufacturing
- Process and assay development for IND-enabling programs
- Biobanking, specimen procurement and cold-chain distribution
- Translational immunology and immune phenotyping
Key Technologies
- Multicolor flow cytometry
- qRT-PCR
- Live-cell imaging
- Multiplex cytokine/protein assays